EZH2 overexpression is associated with poor prognosis in patients with glioma

Previous studies have investigated the prognostic value of enhancer of zeste homolog 2 (EZH2) expression in patients with glioma but conclude contradictory results. We aimed to comprehensively evaluate the prognostic role of EZH2 in glioma by meta-analysis. The databases of PubMed, Embase and Web of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanyang, Yu, Xinguang, Chen, Ling, Zhang, Zhibin, Feng, Shiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352178/
https://www.ncbi.nlm.nih.gov/pubmed/27880940
http://dx.doi.org/10.18632/oncotarget.13478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352178/
https://www.ncbi.nlm.nih.gov/pubmed/27880940
http://dx.doi.org/10.18632/oncotarget.13478

Ejemplares similares